
Please try another search
Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Name | Age | Since | Title |
---|---|---|---|
Binggang Zhang | 62 | 2009 | Director |
Jingbao Wang | 61 | 2020 | Independent Director |
Heping Xu | 66 | 2015 | Supervisory Board Chairman |
Jianzhong Xie | 59 | 2009 | Chairman of the Board |
Changchun Liu | 59 | 2020 | Supervisor |
Yu Ke | 53 | 2021 | Independent Director |
Luwei Zhang | 53 | 2009 | GM & Director |
Hongmin Liu | - | 2024 | Non-Independent Director |
Faliang Jia | 58 | 2021 | Independent Director |
Weidong Wu | 59 | 2015 | Employee Supervisor |
Chao Liu | 39 | 2019 | Deputy GM, Chief Engineer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review